Skip to content

Infectious and Non-infectious Lower Respiratory Diseases in Children With Down Syndrome Followed in Pediatric Pulmonology Consultations in Ile-de-France

Infectious and Non-infectious Lower Respiratory Diseases in Children With Down Syndrome Followed in Pediatric Pulmonology Consultations in Ile-de-France

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06336577
Acronym
ARBT21
Enrollment
108
Registered
2024-03-28
Start date
2024-03-28
Completion date
2024-06-26
Last updated
2024-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Down Syndrome

Keywords

Down syndrome, children, lower respiratory diseases, respiratory infection, respiratory syncytial virus, hemosiderosis, asthma, bronchiolitis

Brief summary

The purpose of this study is to describe infectious and non-infectious lower respiratory tract diseases in children with Down syndrome followed in pediatric pulmonology consultations in Ile de France.

Detailed description

Down syndrome is the most common chromosomal abnormality, affecting 600 to 800 births per year. It results in a clinical picture that combines developmental delay, mental deficiency, facial dysmorphism and visceral malformations. Optimal medical care of Down syndrome patients requires a good knowledge of the different systems affected by the disease, particularly respiratory damage. Numerous articles have been published describing upper respiratory problems in children with Down syndrome. On the other hand, lower respiratory problems causing significant morbidity and mortality remain underestimated and poorly understood in this population. The objective of this study is to describe lower respiratory problems in patients with T21, in order to improve their management. This study will also make it possible to describe more precisely the impact that these attacks have on Down syndrome patients. This study also describe the associated extra-respiratory disorders to improve overall care Finally, the respiratory care of these patients will be described, with the aim of standardizing practices.

Interventions

OTHERlower respiratory tract disease

lower respiratory tract disease

Sponsors

Centre Hospitalier Sud Francilien
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 17 Years

Inclusion criteria

* Child from 0 to 17 years old * Carrier of Down syndrome confirmed by karyotype * Having had follow-up in a pediatric pulmonology consultation for an infectious or non-infectious lower respiratory tract * Not exclusively presenting upper respiratory otorhinolaryngological damage

Exclusion criteria

* Patient under guardianship or curators * Adult or holders of parental authority informed of the study and having objected to it

Design outcomes

Primary

MeasureTime frameDescription
distribution of lower respiratory tract diseasesat day 0number

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026